首页> 外文期刊>Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver >Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
【24h】

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

机译:白藜芦醇改善非酒精性脂肪肝患者的胰岛素抵抗,葡萄糖和脂质代谢:一项随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Non-alcoholic fatty liver disease is a major health problem worldwide. Resveratrol is a natural polyphenol found in edible plants that has a variety of biochemical and physiological effects. Aims: To evaluate the effect of resveratrol on insulin resistance, glucose and lipid metabolism in nonalcoholic fatty liver disease.
机译:背景:非酒精性脂肪肝是世界范围内的主要健康问题。白藜芦醇是在食用植物中发现的天然多酚,具有多种生化和生理作用。目的:评估白藜芦醇对非酒精性脂肪肝疾病中胰岛素抵抗,葡萄糖和脂质代谢的影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号